|
|
||||||||
Ann Thorac Surg 2007;83:1544-1545
© 2007 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, McGill University Health Center, Montréal, Québec, Canada
b Division of General Surgery, Department of Surgery, McGill University Health Center, Montréal, Québec, Canada
c Department of Anesthesia, McGill University Health Center, Montréal, Québec, Canada
Accepted for publication October 4, 2006.
* Address correspondence to Dr Lachapelle, Division of Cardiothoracic Surgery, Department of Surgery, McGill University Health Center, 687 Pine Ave West, Montréal, QC H3A 1A1, Canada (Email: kevin.lachapelle{at}muhc.mcgill.ca).
Despite its initial description more than 20 years ago, combined orthotopic heart and liver transplantation is still performed infrequently. We report a 53-year-old man with familial hypertrophic restrictive cardiomyopathy who presented with right heart failure and end-stage liver failure and required combined orthotopic heart and liver transplantation. Rather then using a staged approach, the surgery was performed using a technique of simultaneous implantation supported by cardiopulmonary bypass. The relative merits of using a simultaneous approach are discussed. The patient had an uneventful postoperative course and went home on postoperative day 14.
This article has been cited by other articles:
![]() |
F.-U. Sack, A. Kristen, H. Goldschmidt, P. A. Schnabel, T. Dengler, A. Koch, and M. Karck Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis Eur J Cardiothorac Surg, February 1, 2008; 33(2): 257 - 262. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |